Literature DB >> 28121346

The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis.

J Ren1, T-H Kuang, J Chen, J-W Yang, Y-X Liu.   

Abstract

OBJECTIVE: Previous studies demonstrated the pivotal role of miR-21 in the pathogenesis and progression of gastric cancer. This meta-analysis was designed to confirm the diagnostic and prognostic value of microRNA-21 (miR-21) in gastric cancer and to investigate the influence of samples on the results of miR-21 detection.
MATERIALS AND METHODS: A literature search was conducted in PubMed and Embase databases up to August 2016. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the summary receiver-operating characteristic (AUC) were calculated by Meta-Disc (version 14.0) or RevMan 5.3 software.
RESULTS: Ten studies including 516 patients with gastric cancer and 239 healthy controls were selected. Pooled sensitivity (0.74, 95% CI: 0.69-0.79), specificity (0.81, 95% CI: 0.76-0.86), PLR (3.85, 95% CI: 3.00-4.94), NLR (0.22, 95% CI: 0.31-0.45), and DOR (13.07, 95% CI: 8.81-19.39) as well as AUC (0.8561 ± 0.0204) indicated the good diagnostic accuracy of miR-21 in detecting gastric cancer. The prognostic value of miR-21 for lymph node metastasis in gastric cancer was also demonstrated by the pooled sensitivity (0.56, 95% CI: 0.48-0.64), specificity (0.62, 95% CI: 0.53-0.71), PLR (2.02, 95% CI: 0.90-4.54), NLR (0.58, 95% CI: 0.45-0.75), and DOR (3.50, 95% CI: 1.04-11.83) as well as AUC (0.6673 ± 0.0469). Subgroup analyses showed that the samples used to detect miR-21 were the source of heterogeneity could affect the diagnostic or prognostic value of miR-21 in gastric cancer.
CONCLUSIONS: miR-21 can be used for the diagnosis of gastric cancer and prognosis of lymph node metastasis in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28121346

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.

Authors:  Bo Fan; Yiying Jin; Hongshuo Zhang; Rui Zhao; Man Sun; Mengfan Sun; Xiaoying Yuan; Wei Wang; Xiaogang Wang; Zhiqi Chen; Wankai Liu; Na Yu; Qun Wang; Tingjiao Liu; Xiancheng Li
Journal:  Int J Oncol       Date:  2019-12-02       Impact factor: 5.650

2.  Diagnostic and prognostic value of microRNA-628 for cancers.

Authors:  Jing-Hua Li; Shan-Shan Sun; Chang-Jin Fu; An-Qi Zhang; Chen Wang; Rong Xu; Shu-Yang Xie; Ping-Yu Wang
Journal:  J Cancer       Date:  2018-04-12       Impact factor: 4.207

3.  Comparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysis.

Authors:  Dan Zhang; Jiewen Zheng; Mengwei Ni; Jiarui Wu; Kuaihuan Wang; Xiaojiao Duan; Xiaomeng Zhang; Bing Zhang
Journal:  Oncotarget       Date:  2017-08-18

4.  Upregulation of the APE1 and H2AX genes and miRNAs involved in DNA damage response and repair in gastric cancer.

Authors:  Fernanda S Manoel-Caetano; Ana Flávia T Rossi; Gabriela Calvet de Morais; Fábio Eduardo Severino; Ana Elizabete Silva
Journal:  Genes Dis       Date:  2019-04-05

5.  Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.

Authors:  Alemu Gebrie
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

6.  A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer.

Authors:  Rui Wu; Sixuan Guo; Shuhui Lai; Guixing Pan; Linyi Zhang; Huanbing Liu
Journal:  BMC Cancer       Date:  2021-06-10       Impact factor: 4.430

Review 7.  The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics.

Authors:  Diana Bautista-Sánchez; Cristian Arriaga-Canon; Abraham Pedroza-Torres; Inti Alberto De La Rosa-Velázquez; Rodrigo González-Barrios; Laura Contreras-Espinosa; Rogelio Montiel-Manríquez; Clementina Castro-Hernández; Verónica Fragoso-Ontiveros; Rosa María Álvarez-Gómez; Luis A Herrera
Journal:  Mol Ther Nucleic Acids       Date:  2020-03-13       Impact factor: 8.886

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.